{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:16:11Z","timestamp":1779207371939,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000297","name":"FRAXA Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000297","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ohio Third Frontier Fund"},{"DOI":"10.13039\/100010327","name":"Cincinnati Children\u2019s Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010327","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-44380-0","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:49:34Z","timestamp":1775040574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acute and chronic dosing of the GABA A alpha 2,3 selective agonist BAER-101 do not alter behavior but may impact auditory-evoked EEG responses in adults with fragile X syndrome"],"prefix":"10.1038","volume":"16","author":[{"given":"Lisa A.","family":"De Stefano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeonseok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig A.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest V.","family":"Pedapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelli C.","family":"Dominick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Shaffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Logan K.","family":"Wink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren M.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Miyakoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"44380_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104794","volume":"138","author":"CR Jonak","year":"2020","unstructured":"Jonak, C. R., Lovelace, J. W., Ethell, I. M., Razak, K. A. & Binder, D. K. Multielectrode array analysis of EEG biomarkers in a mouse model of Fragile X Syndrome. Neurobiol. Dis. 138, 104794 (2020).","journal-title":"Neurobiol. Dis."},{"key":"44380_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-022-03395-9","volume":"5","author":"EV Pedapati","year":"2022","unstructured":"Pedapati, E. V. et al. Neocortical localization and thalamocortical modulation of neuronal hyperexcitability contribute to Fragile X Syndrome. Commun. Biol. 5, 442 (2022).","journal-title":"Commun. Biol."},{"key":"44380_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s11689-017-9191-z","volume":"9","author":"J Wang","year":"2017","unstructured":"Wang, J. et al. A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome. J Neurodevelop. Disord. 9, 11 (2017).","journal-title":"J Neurodevelop. Disord."},{"key":"44380_CR4","doi-asserted-by":"publisher","first-page":"e787","DOI":"10.1038\/tp.2016.48","volume":"6","author":"LE Ethridge","year":"2016","unstructured":"Ethridge, L. E. et al. Reduced habituation of auditory evoked potentials indicate cortical hyper-excitability in Fragile X Syndrome. Transl. Psychiatry 6, e787\u2013e787 (2016).","journal-title":"Transl. Psychiatry"},{"key":"44380_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-017-0140-1","volume":"8","author":"LE Ethridge","year":"2017","unstructured":"Ethridge, L. E. et al. Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in Fragile X Syndrome. Mol. Autism 8, 22 (2017).","journal-title":"Mol. Autism"},{"key":"44380_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.nbd.2018.03.012","volume":"115","author":"JW Lovelace","year":"2018","unstructured":"Lovelace, J. W., Ethell, I. M., Binder, D. K. & Razak, K. A. Translation-relevant EEG phenotypes in a mouse model of Fragile X Syndrome. Neurobiol. Dis. 115, 39\u201348 (2018).","journal-title":"Neurobiol. Dis."},{"key":"44380_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.brainres.2006.08.115","volume":"1121","author":"C D\u2019Hulst","year":"2006","unstructured":"D\u2019Hulst, C. et al. Decreased expression of the GABAA receptor in Fragile X Syndrome. Brain Res. 1121, 238\u2013245 (2006).","journal-title":"Brain Res."},{"key":"44380_CR8","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/nn.3415","volume":"16","author":"JT Gon\u00e7alves","year":"2013","unstructured":"Gon\u00e7alves, J. T., Anstey, J. E., Golshani, P. & Portera-Cailliau, C. Circuit level defects in the developing neocortex of Fragile X mice. Nat. Neurosci. 16, 903\u2013909 (2013).","journal-title":"Nat. Neurosci."},{"key":"44380_CR9","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1152\/jn.00597.2013","volume":"112","author":"BS Martin","year":"2014","unstructured":"Martin, B. S., Corbin, J. G. & Huntsman, M. M. Deficient tonic GABAergic conductance and synaptic balance in the Fragile X Syndrome Amygdala. J. Neurophysiol. 112, 890\u2013902 (2014).","journal-title":"J. Neurophysiol."},{"key":"44380_CR10","doi-asserted-by":"publisher","first-page":"9929","DOI":"10.1523\/JNEUROSCI.1714-10.2010","volume":"30","author":"JL Olmos-Serrano","year":"2010","unstructured":"Olmos-Serrano, J. L. et al. Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the Amygdala in a mouse model of Fragile X Syndrome. J. Neurosci. 30, 9929\u20139938 (2010).","journal-title":"J. Neurosci."},{"key":"44380_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.neulet.2006.11.062","volume":"412","author":"L Selby","year":"2007","unstructured":"Selby, L., Zhang, C. & Sun, Q.-Q. Major defects in neocortical GABAergic inhibitory circuits in mice lacking the Fragile X mental retardation protein. Neurosci. Lett. 412, 227\u2013232 (2007).","journal-title":"Neurosci. Lett."},{"key":"44380_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s11689-022-09455-9","volume":"14","author":"CR Jonak","year":"2022","unstructured":"Jonak, C. R. et al. Baclofen-associated neurophysiologic target engagement across species in Fragile X syndrome. J. Neurodev. Disord. 14, 52 (2022).","journal-title":"J. Neurodev. Disord."},{"key":"44380_CR13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1159\/000332884","volume":"33","author":"JL Olmos-Serrano","year":"2011","unstructured":"Olmos-Serrano, J. L., Corbin, J. G. & Burns, M. P. The GABAA receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of Fragile X Syndrome. Dev. Neurosci. 33, 395\u2013403 (2011).","journal-title":"Dev. Neurosci."},{"key":"44380_CR14","doi-asserted-by":"publisher","unstructured":"De Stefano, L. A. et al. Gaboxadol Increases Resting Theta and Alpha Power without Affecting Evoked Responses in Fragile X Syndrome in a Home-based Setting. Preprint at https:\/\/doi.org\/10.21203\/rs.3.rs-7871579\/v1 (2025).","DOI":"10.21203\/rs.3.rs-7871579\/v1"},{"key":"44380_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.110182","volume":"262","author":"P Janz","year":"2025","unstructured":"Janz, P., Bainier, M., Marashli, S., Gross, S. & Redondo, R. L. Clinically-probed mechanisms of action in Fragile-X syndrome fail to normalize translational EEG phenotypes in Fmr1 knockout mice. Neuropharmacology 262, 110182 (2025).","journal-title":"Neuropharmacology"},{"key":"44380_CR16","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0306-4522(00)00442-5","volume":"101","author":"S Pirker","year":"2000","unstructured":"Pirker, S., Schwarzer, C., Wieselthaler, A., Sieghart, W. & Sperk, G. GABAA receptors: Immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 101, 815\u2013850 (2000).","journal-title":"Neuroscience"},{"key":"44380_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhaf141","author":"M Miyakoshi","year":"2025","unstructured":"Miyakoshi, M. et al. Hyper-extralemniscal model of Fragile X Syndrome. Cereb. Cortex https:\/\/doi.org\/10.1093\/cercor\/bhaf141 (2025).","journal-title":"Cereb. Cortex"},{"key":"44380_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.678090","volume":"12","author":"TL Schaefer","year":"2021","unstructured":"Schaefer, T. L. et al. GABAA Alpha 2,3 modulation improves select phenotypes in a mouse model of fragile X syndrome. Front. Psychiatry 12, 678090 (2021).","journal-title":"Front. Psychiatry"},{"key":"44380_CR19","first-page":"283","volume":"100","author":"MG Aman","year":"1995","unstructured":"Aman, M. G., Burrow, W. H. & Wolford, P. L. The Aberrant Behavior Checklist-Community: Factor validity and effect of subject variables for adults in group homes. Am. J. Ment. Retard. 100, 283\u2013292 (1995).","journal-title":"Am. J. Ment. Retard."},{"key":"44380_CR20","doi-asserted-by":"crossref","unstructured":"Guy, W. Clinical global impression. Assessment manual for Psychopharmacology 217\u2013222 (1976).","DOI":"10.1037\/e591322011-001"},{"key":"44380_CR21","volume-title":"The Stanford-Binet Intelligence Scales","author":"GH Roid","year":"2012","unstructured":"Roid, G. H. & Pomplun, M. The Stanford-Binet Intelligence Scales 654 (The Guilford Press, 2012)."},{"key":"44380_CR22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1076\/jcen.20.3.310.823","volume":"20","author":"C Randolph","year":"1998","unstructured":"Randolph, C., Tierney, M. C., Mohr, E. & Chase, T. N. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary clinical validity. J. Clin. Exp. Neuropsychol. 20, 310\u2013319 (1998).","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"44380_CR23","volume-title":"Woodcock-Johnson Tests of Cognitive Abilities","author":"RW Woodcock","year":"2001","unstructured":"Woodcock, R. W., McGrew, K. S. & Mather, N. Woodcock-Johnson Tests of Cognitive Abilities (Riverside, 2001)."},{"key":"44380_CR24","unstructured":"Zimmermann, P., Gondan, M. & Fimm, B. KITAP Testbatterie Zur Aufmerksamkeitspr\u00fcfung F\u00fcr Kinder. Handbuch. (Freiburg: Psytest, 2004)."},{"key":"44380_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.pediatrneurol.2020.04.019","volume":"110","author":"E Berry-Kravis","year":"2020","unstructured":"Berry-Kravis, E. et al. A double-blind, randomized, placebo-controlled clinical study of Trofinetide in the treatment of Fragile X Syndrome. Pediatr. Neurol. 110, 30\u201341 (2020).","journal-title":"Pediatr. Neurol."},{"key":"44380_CR26","unstructured":"Snape, M., Horrigan, J. & Glass, L. Improving outcome measures for fragile X syndrome clinical trials: Development of fragile X syndrome specific rating scales. Society for the Study of Behavioral Phenotypes New York City (2014)."},{"key":"44380_CR27","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s10803-011-1370-2","volume":"42","author":"SM Sansone","year":"2012","unstructured":"Sansone, S. M. et al. Psychometric study of the Aberrant Behavior Checklist in Fragile X Syndrome and implications for targeted treatment. J. Autism Dev. Disord. 42, 1377\u20131392 (2012).","journal-title":"J. Autism Dev. Disord."},{"key":"44380_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s11689-016-9167-4","volume":"8","author":"D Hessl","year":"2016","unstructured":"Hessl, D. et al. The NIH Toolbox Cognitive Battery for intellectual disabilities: Three preliminary studies and future directions. J Neurodevelop Disord. 8, 35 (2016).","journal-title":"J Neurodevelop Disord."},{"key":"44380_CR29","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2024.0103","author":"WS McKinney","year":"2024","unstructured":"McKinney, W. S. et al. Results from a double-blind, randomized, placebo-controlled, single-dose, crossover trial of lovastatin or minocycline in fragile X syndrome. J. Child Adolescent Psychopharmacol. https:\/\/doi.org\/10.1089\/cap.2024.0103 (2024).","journal-title":"J. Child Adolescent Psychopharmacol."},{"key":"44380_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13229-022-00527-0","volume":"13","author":"LM Schmitt","year":"2022","unstructured":"Schmitt, L. M. et al. Altered frontal connectivity as a mechanism for executive function deficits in Fragile X syndrome. Mol. Autism. 13, 47 (2022).","journal-title":"Mol. Autism."},{"key":"44380_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jneumeth.2003.10.009","volume":"134","author":"A Delorme","year":"2004","unstructured":"Delorme, A. & Makeig, S. EEGLAB: An open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J. Neurosci. Methods. 134, 9\u201321 (2004).","journal-title":"J. Neurosci. Methods."},{"key":"44380_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fninf.2015.00016","volume":"9","author":"N Bigdely-Shamlo","year":"2015","unstructured":"Bigdely-Shamlo, N., Mullen, T., Kothe, C., Su, K.-M. & Robbins, K. A. The PREP pipeline: Standardized preprocessing for large-scale EEG analysis. Front. Neuroinform. 9, 16 (2015).","journal-title":"Front. Neuroinform."},{"key":"44380_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fninf.2020.597079","author":"M Miyakoshi","year":"2021","unstructured":"Miyakoshi, M., Schmitt, L. M., Erickson, C. A., Sweeney, J. A. & Pedapati, E. V. Can we push the \u201cquasi-perfect artifact rejection\u201d even closer to perfection?. Front. Neuroinform. https:\/\/doi.org\/10.3389\/fninf.2020.597079 (2021).","journal-title":"Front. Neuroinform."},{"key":"44380_CR34","unstructured":"Mullen, T. CleanLine. (2012)."},{"key":"44380_CR35","doi-asserted-by":"publisher","DOI":"10.1088\/1741-2560\/10\/5\/056014","volume":"10","author":"CA Kothe","year":"2013","unstructured":"Kothe, C. A. & Makeig, S. BCILAB: A platform for brain\u2013computer interface development. J. Neural Eng. 10, 056014 (2013).","journal-title":"J. Neural Eng."},{"key":"44380_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsad241","author":"M Miyakoshi","year":"2023","unstructured":"Miyakoshi, M. Artifact subspace reconstruction: A candidate for a dream solution for EEG studies, sleep or awake. Sleep https:\/\/doi.org\/10.1093\/sleep\/zsad241 (2023).","journal-title":"Sleep"},{"key":"44380_CR37","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1109\/TBME.2015.2481482","volume":"62","author":"TR Mullen","year":"2015","unstructured":"Mullen, T. R. et al. Real-time neuroimaging and cognitive monitoring using wearable dry EEG. IEEE Trans. Biomed. Eng. 62, 2553\u20132567 (2015).","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"44380_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2025.110465","volume":"420","author":"H Kim","year":"2025","unstructured":"Kim, H., Chang, C.-Y., Kothe, C., Iversen, J. R. & Miyakoshi, M. Juggler\u2019s ASR: Unpacking the principles of artifact subspace reconstruction for revision toward extreme MoBI. J. Neurosci. Methods. 420, 110465 (2025).","journal-title":"J. Neurosci. Methods."},{"key":"44380_CR39","doi-asserted-by":"publisher","first-page":"1064138","DOI":"10.3389\/frsip.2023.1064138","volume":"3","author":"H Kim","year":"2023","unstructured":"Kim, H. et al. ICA\u2019s bug: How ghost ICs emerge from effective rank deficiency caused by EEG electrode interpolation and incorrect re-referencing. Front. Signal Process. 3, 1064138 (2023).","journal-title":"Front. Signal Process."},{"key":"44380_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates, D., M\u00e4chler, M., Bolker, B. & Walker, S. Fitting linear mixed-effects models using lme4. J. Stat. Softw. 67, 1\u201348 (2015).","journal-title":"J. Stat. Softw."},{"key":"44380_CR41","unstructured":"Lenth, R. emmeans: Estimated Marginal Means, aka Least-Squares Means. R package version 1.11.1. (2025)."},{"key":"44380_CR42","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing (2024)."},{"key":"44380_CR43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-3-319-24277-4_9","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"H Wickham","year":"2016","unstructured":"Wickham, H. Data analysis. In ggplot2: Elegant Graphics for Data Analysis 189\u2013201 (Springer, 2016)."},{"key":"44380_CR44","unstructured":"Gamer, M., Lemon, J., & IFPS. irr: Various Coefficients of Interrater Reliability and Agreement. R package version 0.84.1. (2019)."},{"key":"44380_CR45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jneumeth.2016.04.015","volume":"268","author":"T Melman","year":"2016","unstructured":"Melman, T. & Victor, J. D. Robust power spectral estimation for EEG data. J. Neurosci. Methods. 268, 14\u201322 (2016).","journal-title":"J. Neurosci. Methods."},{"key":"44380_CR46","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s10803-008-0564-8","volume":"38","author":"E Berry-Kravis","year":"2008","unstructured":"Berry-Kravis, E., Sumis, A., Kim, O.-K., Lara, R. & Wuu, J. Characterization of potential outcome measures for future clinical trials in Fragile X syndrome. J. Autism Dev. Disord. 38, 1751\u20131757 (2008).","journal-title":"J. Autism Dev. Disord."},{"key":"44380_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/1866-1955-4-2","volume":"4","author":"A Knox","year":"2012","unstructured":"Knox, A. et al. Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS). J. Neurodev. Disord. 4, 2 (2012).","journal-title":"J. Neurodev. Disord."},{"key":"44380_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bionps.2023.100070","volume":"9","author":"R Liu","year":"2023","unstructured":"Liu, R. et al. Reliability of resting-state electrophysiology in Fragile X syndrome. Biomark. Neuropsychiatry 9, 100070 (2023).","journal-title":"Biomark. Neuropsychiatry"},{"key":"44380_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2021.106809","volume":"178","author":"M Miyakoshi","year":"2021","unstructured":"Miyakoshi, M. et al. Automated preprocessing and phase-amplitude coupling analysis of scalp EEG discriminates infantile spasms from controls during wakefulness. Epilepsy Res. 178, 106809 (2021).","journal-title":"Epilepsy Res."},{"key":"44380_CR50","doi-asserted-by":"crossref","unstructured":"Xia, Chen Gabri\u00ebl, Jacobs Marieke, de Kam Judith, Jaeger Jaakko, Lappalainen Paul, Maruff Mark A., Smith Alan J., Cross Adam, Cohen Joop, van Gerven (2014)  The central nervous system effects of the partial GABA\u2010 A\u03b123\u2010selective receptor modulator AZD7325 in comparison with lorazepam in healthy males British Journal of Clinical Pharmacology 78(6) 1298-1314 10.1111\/bcp.2014.78.issue-6 10.1111\/bcp.12413","DOI":"10.1111\/bcp.12413"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44380-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44380-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44380-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:03:05Z","timestamp":1779206585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44380-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["44380"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-44380-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8123031\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"15 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was funded by the Cincinnati Children\u2019s Hospital Research Foundation, the State of Ohio\u2019s Ohio Development Services Agency, and the FRAXA Research Foundation. Drug and matching placebo were provided by Baergic Bio, Inc. CAE is a co-inventor on a patent describing the method of use of BAER-101 in fragile X syndrome with the patent held by the Cincinnati Children\u2019s Hospital Research Foundation. The authors otherwise have no conflicts or financial agreements in direct conflict with any information reported in this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15404"}}